Search Results 471-480 of 37814 for Two-phase

  1. Stage 4 (Metastatic) Colon Cancer Clinical Trials - Mayo Clinic Research

    Approximately 687 subjects will be randomized to one of the following treatment arms in a 2:1 ratio, fruquintinib plus BSC or placebo plus BSC. Regorafenib in ...

  2. A Study to Evaluate AuTophagy Activation for Cardiomyopathy Due to Anthracycline tReatment - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  3. Hodgkin Clinical Trials - Mayo Clinic Research

    Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma Rochester, MN. This open-label, randomized, 2-arm, multicenter, phase 3 ...

  4. Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other Myelodysplastic /Myeloproliferative Neoplasias, and Acute Myeloid Leukemia - Mayo Clinic

    A Phase 2 study to investigate the antitumor activity in terms of overall response rate (ORR) of tipifarnib in approximately 20 eligible subjects with CMML.

  5. A Phase I study of Epalrestat Therapy in a Single Patient with Phosphomannomutase Deficiency (PMM2-CDG) - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  6. Neurology - Clinical trials

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

  7. Cellular Therapy Clinical Trials - Mayo Clinic Research

    ... Phase 2 dose (RP2D). Patient Perceptions of the Impact of Unproven Stem Cell Corrections Rochester, MN. The purpose of this study is to explore patients ...

  8. A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma - Mayo Clinic

    Overview. Tab Title Description. Study typeInterventional Study phase2/3. Study ... * Two scans to confirm progression are required: at least 1 scan at ...

  9. Synovial Sarcoma Clinical Trials - Mayo Clinic Research

    ... Phase 2 dose (RP2D) for CFT8634 in subjects with locally advanced or metastatic SMARCB1-perturbed cancers. Phase 2 only: To assess preliminary antitumor ...

  10. Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...